These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
133 related items for PubMed ID: 15995147
1. Expression analysis of PMP22/Gas3 in premalignant and malignant pancreatic lesions. Li J, Kleeff J, Esposito I, Kayed H, Felix K, Giese T, Büchler MW, Friess H. J Histochem Cytochem; 2005 Jul; 53(7):885-93. PubMed ID: 15995147 [Abstract] [Full Text] [Related]
2. Localization of the human hedgehog-interacting protein (Hip) in the normal and diseased pancreas. Kayed H, Kleeff J, Esposito I, Giese T, Keleg S, Giese N, Büchler MW, Friess H. Mol Carcinog; 2005 Apr; 42(4):183-92. PubMed ID: 15754313 [Abstract] [Full Text] [Related]
3. BGLAP is expressed in pancreatic cancer cells and increases their growth and invasion. Kayed H, Bekasi S, Keleg S, Michalski CW, Giese T, Friess H, Kleeff J. Mol Cancer; 2007 Dec 28; 6():83. PubMed ID: 18163903 [Abstract] [Full Text] [Related]
4. Tenascin C and annexin II expression in the process of pancreatic carcinogenesis. Esposito I, Penzel R, Chaib-Harrireche M, Barcena U, Bergmann F, Riedl S, Kayed H, Giese N, Kleeff J, Friess H, Schirmacher P. J Pathol; 2006 Apr 28; 208(5):673-85. PubMed ID: 16450333 [Abstract] [Full Text] [Related]
5. Loss of ONECUT1 expression in human pancreatic cancer cells. Jiang X, Zhang W, Kayed H, Zheng P, Giese NA, Friess H, Kleeff J. Oncol Rep; 2008 Jan 28; 19(1):157-63. PubMed ID: 18097590 [Abstract] [Full Text] [Related]
6. Over-expression of S100A2 in pancreatic cancer correlates with progression and poor prognosis. Ohuchida K, Mizumoto K, Miyasaka Y, Yu J, Cui L, Yamaguchi H, Toma H, Takahata S, Sato N, Nagai E, Yamaguchi K, Tsuneyoshi M, Tanaka M. J Pathol; 2007 Nov 28; 213(3):275-82. PubMed ID: 17940995 [Abstract] [Full Text] [Related]
8. Sonic hedgehog is an early developmental marker of intraductal papillary mucinous neoplasms: clinical implications of mRNA levels in pancreatic juice. Ohuchida K, Mizumoto K, Fujita H, Yamaguchi H, Konomi H, Nagai E, Yamaguchi K, Tsuneyoshi M, Tanaka M. J Pathol; 2006 Sep 28; 210(1):42-8. PubMed ID: 16794990 [Abstract] [Full Text] [Related]
9. In vitro modeling of human pancreatic duct epithelial cell transformation defines gene expression changes induced by K-ras oncogenic activation in pancreatic carcinogenesis. Qian J, Niu J, Li M, Chiao PJ, Tsao MS. Cancer Res; 2005 Jun 15; 65(12):5045-53. PubMed ID: 15958547 [Abstract] [Full Text] [Related]
10. Overexpression of fibroblast growth factor receptor 4 in high-grade pancreatic intraepithelial neoplasia and pancreatic ductal adenocarcinoma. Motoda N, Matsuda Y, Onda M, Ishiwata T, Uchida E, Naito Z. Int J Oncol; 2011 Jan 15; 38(1):133-43. PubMed ID: 21109934 [Abstract] [Full Text] [Related]
11. Cripto-1 overexpression is involved in the tumorigenesis of gastric-type and pancreatobiliary-type intraductal papillary mucinous neoplasms of the pancreas. Hong SP, Lee EK, Park JY, Jeon TJ, Bang S, Park S, Chung JB, Lee WJ, Kim H, Song SY. Oncol Rep; 2009 Jan 15; 21(1):19-24. PubMed ID: 19082438 [Abstract] [Full Text] [Related]
12. Enhanced expression of 14-3-3sigma in pancreatic cancer and its role in cell cycle regulation and apoptosis. Guweidhi A, Kleeff J, Giese N, El Fitori J, Ketterer K, Giese T, Büchler MW, Korc M, Friess H. Carcinogenesis; 2004 Sep 15; 25(9):1575-85. PubMed ID: 15073049 [Abstract] [Full Text] [Related]
13. S100A11, a putative tumor suppressor gene, is overexpressed in pancreatic carcinogenesis. Ohuchida K, Mizumoto K, Ohhashi S, Yamaguchi H, Konomi H, Nagai E, Yamaguchi K, Tsuneyoshi M, Tanaka M. Clin Cancer Res; 2006 Sep 15; 12(18):5417-22. PubMed ID: 17000675 [Abstract] [Full Text] [Related]
14. Significance of cellular distribution of ezrin in pancreatic cystic neoplasms and ductal adenocarcinoma. Yeh TS, Tseng JH, Liu NJ, Chen TC, Jan YY, Chen MF. Arch Surg; 2005 Dec 15; 140(12):1184-90. PubMed ID: 16365240 [Abstract] [Full Text] [Related]
15. Uroguanylin inhibits proliferation of pancreatic cancer cells. Kloeters O, Friess H, Giese N, Buechler MW, Cetin Y, Kulaksiz H. Scand J Gastroenterol; 2008 Dec 15; 43(4):447-55. PubMed ID: 18365910 [Abstract] [Full Text] [Related]
16. The MUC gene family: their role in diagnosis and early detection of pancreatic cancer. Ringel J, Löhr M. Mol Cancer; 2003 Jan 07; 2():9. PubMed ID: 12556240 [Abstract] [Full Text] [Related]
17. S100P is an early developmental marker of pancreatic carcinogenesis. Ohuchida K, Mizumoto K, Egami T, Yamaguchi H, Fujii K, Konomi H, Nagai E, Yamaguchi K, Tsuneyoshi M, Tanaka M. Clin Cancer Res; 2006 Sep 15; 12(18):5411-6. PubMed ID: 17000674 [Abstract] [Full Text] [Related]
18. Expression and potential function of the CXC chemokine CXCL16 in pancreatic ductal adenocarcinoma. Wente MN, Gaida MM, Mayer C, Michalski CW, Haag N, Giese T, Felix K, Bergmann F, Giese NA, Friess H. Int J Oncol; 2008 Aug 15; 33(2):297-308. PubMed ID: 18636150 [Abstract] [Full Text] [Related]
19. Protease-activated receptor-2 regulates cell proliferation and enhances cyclooxygenase-2 mRNA expression in human pancreatic cancer cells. Yada K, Shibata K, Matsumoto T, Ohta M, Yokoyama S, Kitano S. J Surg Oncol; 2005 Feb 01; 89(2):79-85. PubMed ID: 15660373 [Abstract] [Full Text] [Related]
20. Analysis of the pancreatic tumor progression by a quantitative proteomic approach and immunhistochemical validation. Sitek B, Sipos B, Alkatout I, Poschmann G, Stephan C, Schulenborg T, Marcus K, Lüttges J, Dittert DD, Baretton G, Schmiegel W, Hahn SA, Klöppel G, Meyer HE, Stühler K. J Proteome Res; 2009 Apr 01; 8(4):1647-56. PubMed ID: 19714807 [Abstract] [Full Text] [Related] Page: [Next] [New Search]